Innoviva, Inc. 8-K
Leadership change
Small and DiPaolo leave the board to focus on Syndeio BioSciences; Josephine Linden joins as an independent director.
Filed 2026-05-18 16:21 ET
- 5.02 Officer/director change
- 9.01 Financial Statements and Exhibits
Summary
Two directors resigned and a new independent director was appointed. Derek Small and Mark DiPaolo resigned on 5/12/2026 to focus on Syndeio BioSciences, where Small is CEO and DiPaolo is expected to take an executive role. Josephine Linden joined the board on 5/18/2026 and is expected to serve on its Audit Committee.
Key Figures
- Director compensation: $125,000 in initial restricted stock units (RSUs), vesting in equal annual installments over two years; $206,250 in prorated annual RSUs and options for 9,166 shares, each vesting in one installment by the earlier of the next annual stockholders’ meeting or the first anniversary of her appointment. Unvested awards accelerate upon death, disability or a change in control.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3